Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy

Autor: Ben G. L. Vanneste, Aswin L. Hoffmann, Florian Buettner, Michael Pinkawa, Philippe Lambin
Přispěvatelé: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Promovendi ODB, Precision Medicine
Jazyk: angličtina
Rok vydání: 2019
Předmět:
medicine.medical_treatment
MODULATED RADIATION-THERAPY
Brachytherapy
CONFORMAL RADIOTHERAPY
R895-920
Rectum
HISTOGRAMS
Dose constraints
Dose-surface maps
BALLOON
Article
030218 nuclear medicine & medical imaging
Rectum spacer
POLYETHYLENE-GLYCOL HYDROGEL
03 medical and health sciences
Prostate cancer
Medical physics. Medical radiology. Nuclear medicine
0302 clinical medicine
QUALITY-OF-LIFE
medicine
Radiology
Nuclear Medicine and imaging

RC254-282
Radiotherapy
business.industry
BRACHYTHERAPY
Toxicity reduction
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.disease
3. Good health
Radiation therapy
REDUCTION
medicine.anatomical_structure
Oncology
Rectal wall
030220 oncology & carcinogenesis
GASTROINTESTINAL TOXICITY
Sphincter
TRIAL
business
Complication
Nuclear medicine
Zdroj: Clinical and Translational Radiation Oncology, Vol 14, Iss, Pp 17-24 (2019)
Clinical and Translational Radiation Oncology 14(2019), 17-24
Clinical and Translational Radiation Oncology, 14, 17-24. Elsevier Ireland Ltd
Clinical and Translational Radiation Oncology
ISSN: 2405-6308
Popis: Highlights • Implantable rectum spacers (IRS) separate the ano-rectal wall (ARW) from the prostate. • Dose-surface maps (DSMs) are a tool to take spatio-dosimetric info into account. • Spatio-dosimetric differences in ARW DSMs exist comparing IMRT with and without IRS. • IRS reduces the lateral and longitudinal extent of areas >50 Gy. • IRS reduces these high-dose areas in anterior and superior-inferior directions.
Background and purpose To evaluate spatial differences in dose distributions of the ano-rectal wall (ARW) using dose-surface maps (DSMs) between prostate cancer patients receiving intensity-modulated radiation therapy with and without implantable rectum spacer (IMRT+IRS; IMRT−IRS, respectively), and to correlate this with late gastro-intestinal (GI) toxicities using validated spatial and non-spatial normal-tissue complication probability (NTCP) models. Materials and methods For 26 patients DSMs of the ARW were generated. From the DSMs various shape-based dose measures were calculated at different dose levels: lateral extent, longitudinal extent, and eccentricity. The contiguity of the ARW dose distribution was assessed by the contiguous-DSH (cDSH). Predicted complication rates between IMRT+IRS and IMRT−IRS plans were assessed using a spatial NTCP model and compared against a non-spatial NTCP model. Results Dose surface maps are generated for prostate radiotherapy using an IRS. Lateral extent, longitudinal extent and cDSH were significantly lower in IMRT+IRS than for IMRT−IRS at high-dose levels. Largest significant differences were observed for cDSH at dose levels >50 Gy, followed by lateral extent at doses >57 Gy, and longitudinal extent in anterior and superior-inferior directions. Significant decreases (p = 0.01) in median rectal and anal NTCPs (respectively, Gr 2 late rectal bleeding and subjective sphincter control) were predicted when using an IRS. Conclusions Local-dose effects are predicted to be significantly reduced by an IRS. The spatial NTCP model predicts a significant decrease in Gr 2 late rectal bleeding and subjective sphincter control. Dose constraints can be improved for current clinical treatment planning.
Databáze: OpenAIRE